Literature DB >> 30023125

Invited letter to the editor on the editorial on "Clinical staging of NSCLC: current evidence and implications for adjuvant chemotherapy".

David Jonathan Heineman1, Johannes Marlene Daniels2, Wilhelmina Hendrika Schreurs3.   

Abstract

Entities:  

Year:  2018        PMID： 30023125      PMCID： PMC6036038          DOI： 10.21037/jtd.2018.04.121

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  12 in total

1.  Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Authors:  Gary M Strauss; James E Herndon; Michael A Maddaus; David W Johnstone; Elizabeth A Johnson; David H Harpole; Heidi H Gillenwater; Dorothy M Watson; David J Sugarbaker; Richard L Schilsky; Everett E Vokes; Mark R Green
Journal:  J Clin Oncol       Date:  2008-09-22       Impact factor: 44.544

2.  New classification-new problems to solve.

Authors:  Marcin Zieliński; Robert Kwiatkowski
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

3.  Adjuvant Chemotherapy After Lobectomy for T1-2N0 Non-Small Cell Lung Cancer: Are the Guidelines Supported?

Authors:  Paul J Speicher; Lin Gu; Xiaofei Wang; Matthew G Hartwig; Thomas A D'Amico; Mark F Berry
Journal:  J Natl Compr Canc Netw       Date:  2015-06       Impact factor: 11.908

Review 4.  Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.

Authors:  Mark G Kris; Laurie E Gaspar; Jamie E Chaft; Erin B Kennedy; Christopher G Azzoli; Peter M Ellis; Steven H Lin; Harvey I Pass; Rahul Seth; Frances A Shepherd; David R Spigel; John R Strawn; Yee C Ung; Michael Weyant
Journal:  J Clin Oncol       Date:  2017-04-24       Impact factor: 44.544

5.  Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer?

Authors:  Benjamin D Kozower; Bryan F Meyers; Carolyn E Reed; David R Jones; Paul A Decker; Joe B Putnam
Journal:  Ann Thorac Surg       Date:  2008-04       Impact factor: 4.330

6.  Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).

Authors:  Wilfried Ernst Erich Eberhardt; Christoph Pöttgen; Thomas Christoph Gauler; Godehard Friedel; Stefanie Veit; Vanessa Heinrich; Stefan Welter; Wilfried Budach; Werner Spengler; Martin Kimmich; Berthold Fischer; Heinz Schmidberger; Dirk De Ruysscher; Claus Belka; Sebastian Cordes; Rodrigo Hepp; Diana Lütke-Brintrup; Nils Lehmann; Martin Schuler; Karl-Heinz Jöckel; Georgios Stamatis; Martin Stuschke
Journal:  J Clin Oncol       Date:  2015-11-02       Impact factor: 44.544

7.  Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC.

Authors:  Daniel Morgensztern; Lingling Du; Saiama N Waqar; Aalok Patel; Pamela Samson; Siddhartha Devarakonda; Feng Gao; Cliff G Robinson; Jeffrey Bradley; Maria Baggstrom; Ashiq Masood; Ramaswamy Govindan; Varun Puri
Journal:  J Thorac Oncol       Date:  2016-06-08       Impact factor: 15.609

8.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

Authors:  Peter Goldstraw; Kari Chansky; John Crowley; Ramon Rami-Porta; Hisao Asamura; Wilfried E E Eberhardt; Andrew G Nicholson; Patti Groome; Alan Mitchell; Vanessa Bolejack
Journal:  J Thorac Oncol       Date:  2016-01       Impact factor: 15.609

9.  Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  John A Howington; Matthew G Blum; Andrew C Chang; Alex A Balekian; Sudish C Murthy
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

Review 10.  Clinical staging of NSCLC: current evidence and implications for adjuvant chemotherapy.

Authors:  David J Heineman; Johannes M Daniels; Wilhelmina H Schreurs
Journal:  Ther Adv Med Oncol       Date:  2017-08-02       Impact factor: 8.168
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.